Windlas Biotech Share PriceWindlas Biotech

₹356.55
1.5 (0.42%)
As on 30 September, 2023 | 06:06 BSE: 543329 NSE: WINDLASISIN: INE0H5O01029

Windlas Biotech Performance

Day Range

  • Low 352.35
  • High 360
356.55

52 Week Range

  • Low 212
  • High 420.9
356.55
  • Open Price355.05
  • Previous Close355.05
  • Volume21725

Start SIP in Windlas Biotech

Start SIP

Windlas Biotech Share Price

  • Over 1 Month -0.14%
  • Over 3 Month 16.75%
  • Over 6 Month 58.64%
  • Over 1 Year 54.82%

Windlas Biotech Key Statistics

P/E Ratio 16.5
PEG Ratio 1.8
Market Cap Cr 742
Price to Book Ratio 1.8
EPS 19.7
Dividend 1.1
Relative Strength Index 48.04
Money Flow Index 56.22
MACD Signal -1.06
Average True Range 13.08

Windlas Biotech Investment Rating

  • Master Rating:
  • Windlas Biotech has an operating revenue of Rs. 537.93 Cr. on a trailing 12-month basis. An annual revenue growth of 11% is good, Pre-tax margin of 11% is healthy, ROE of 10% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 24% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 48 which is a POOR score indicating inconsistency in earnings, a RS Rating of 72 which is FAIR indicating the recent price performance, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 40 indicates it belongs to a strong industry group of Medical-Ethical Drugs and a Master Score of B is close to being the best. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Windlas Biotech Financials
IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 145141120133120122
Operating Expenses Qtr Cr 128124106117106108
Operating Profit Qtr Cr 171614161414
Depreciation Qtr Cr 343333
Interest Qtr Cr 000000
Tax Qtr Cr 44434-1
Net Profit Qtr Cr 12119121015
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 523473
Operating Expenses Annual Cr 453413
Operating Profit Annual in Cr 6053
Depreciation Cr 1212
Interest Annual Cr 11
Tax Annual Cr 147
Net Profit Annual Cr 4339
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 9
Cash from Investing Activity Annual Cr -154
Cash from Financing Annual Activity Cr 130
Net Cash Flow Annual Cr -15
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 403395
Fixed Assets Annual Cr 12499
Total Non Current Assets Annual Cr 175109
Total Current Assets Annual Cr 354382
Total Assets Annual Cr 529491
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 192181
ROE Annual % 1110
ROCE Annual % 1412
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 1413
IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 145141120133120122
Operating Expenses Qtr Cr 128124106117106108
Operating Profit Qtr Cr 171614161414
Depreciation Qtr Cr 343333
Interest Qtr Cr 000000
Tax Qtr Cr 44434-1
Net Profit Qtr Cr 12119121015
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 523473
Operating Expenses Annual Cr 453414
Operating Profit Annual in Cr 6052
Depreciation Cr 1212
Interest Annual Cr 11
Tax Annual Cr 147
Net Profit Annual Cr 4338
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 9
Cash from Investing Activity Annual Cr -155
Cash from Financing Annual Activity Cr 130
Net Cash Flow Annual Cr -15
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 402395
Fixed Assets Annual Cr 12499
Total Non Current Assets Annual Cr 175113
Total Current Assets Annual Cr 354378
Total Assets Annual Cr 529491
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 192181
ROE Annual % 1110
ROCE Annual % 1412
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 1413

Windlas Biotech Technicals

EMA & SMA

Current Price
₹356.55
1.5 (0.42%)
  • Bullish Moving Average
  • ___
  • 10
  • Bearish Moving Average
  • ___
  • 6
  • 20 Day
  • ₹359.32
  • 50 Day
  • ₹352.41
  • 100 Day
  • ₹330.5
  • 200 Day
  • ₹303.25
  • 20 Day
  • ₹364.79
  • 50 Day
  • ₹358.45
  • 100 Day
  • ₹325.04
  • 200 Day
  • ₹286.62

Windlas Biotech Resistance and Support

PIVOT
₹356.3
Resistance
First Resistance ₹360.25
Second Resistance ₹363.95
Third Resistance ₹367.9
RSI 48.04
MFI 56.22
MACD Single Line -1.06
MACD -2.88
Support
First Resistance ₹352.6
Second Resistance ₹348.65
Third Resistance ₹344.95

Windlas Biotech Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 23,976 1,391,807 58.05
Week 33,690 1,892,042 56.16
1 Month 59,491 2,853,781 47.97
6 Month 87,454 3,848,842 44.01

Windlas Biotech Result Highlights

Windlas Biotech Synopsis

NSE-Medical-Ethical Drugs

Windlas Biotech belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 513.08 Cr. and Equity Capital is Rs. 10.46 Cr. for the Year ended 31/03/2023. Windlas Biotech Ltd. is a Public Limited Listed company incorporated on 19/02/2001 and has its registered office in the State of Uttarakhand/Uttaranchal, India. Company’s Corporate Identification Number(CIN) is L74899UR2001PLC033407 and registration number is 033407.
Market Cap 742
Sales 538
Shares in Float 0.77
No of funds 11
Yield 1.12
Book Value 1.85
U/D Vol ratio 1.7
LTDebt / Equity
Alpha 0.15
Beta 0.56

Windlas Biotech

Owner NameJun-23Apr-23Mar-23Feb-23
Promoters 62.82%62.44%62.38%61.22%
Mutual Funds 10.51%10.65%10.64%11.32%
Foreign Portfolio Investors 0.8%1.23%1.32%1.4%
Financial Institutions/ Banks 0.04%0.04%0.04%0.04%
Individual Investors 22.01%22%21.98%22.18%
Others 3.82%3.64%3.64%3.84%

Windlas Biotech Management

Name Designation
Mr. Vivek Dhariwal Chairman & Ind.Director
Mr. Hitesh Windlass Managing Director
Mr. Manoj Kumar Windlass Joint Managing Director
Mr. Pawan Kumar Sharma Executive Director
Mr. Ashok Kumar Windlass Whole Time Director
Mrs. Prachi Jain Windlass Non Executive Director
Mr. Srinivasan Venkataraman Ind. Non-Executive Director
Mr. Gaurav Gulati Ind. Non-Executive Director

Windlas Biotech Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Windlas Biotech Corporate Action

Date Purpose Remarks
2023-08-08 Quarterly Results
2023-05-05 Audited Results & Final Dividend
2023-02-08 Quarterly Results
2022-11-08 Quarterly Results
2022-08-04 Quarterly Results

Windlas Biotech MF Shareholding

Name Amount(cr)
ICICI Prudential Smallcap Fund Growth 6989
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth 3174
UTI Healthcare Fund Regular Plan Growth 776
Sundaram Emerging Small Cap Ser VII Regular Transfer Inc Dist cum Cap Wdrl 160
Sundaram L/T Micro cap Tax Advantage Fund Sries III Regular Growth 78
  • Company Name
  • CMP
  • Chg(%)
  • Company Name
  • CMP
  • Chg(%)

Windlas Biotech FAQs

What is Share Price of Windlas Biotech ?

Windlas Biotech share price is ₹356 As on 30 September, 2023 | 05:52

What is the Market Cap of Windlas Biotech ?

The Market Cap of Windlas Biotech is ₹741.6 Cr As on 30 September, 2023 | 05:52

What is the P/E ratio of Windlas Biotech ?

The P/E ratio of Windlas Biotech is 16.5 As on 30 September, 2023 | 05:52

What is the PB ratio of Windlas Biotech ?

The PB ratio of Windlas Biotech is 1.8 As on 30 September, 2023 | 05:52

Q2FY23